Owonikoko, Taofeek K, Kyriakos P Papadopoulos, Melissa L Johnson, and Et al. 2018. “Phase 1 Study of Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients With Unresectable Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Final Efficacy and Safety Data”. SKIN The Journal of Cutaneous Medicine 2 (December):S78. https://doi.org/10.25251/skin.2.supp.78.